Related Experiment Video
Updated: Jun 6, 2026

PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions
Published on: July 27, 2017
Pipecolic acid derivatives as small-molecule inhibitors of the Legionella MIP protein
Christina Juli1, Martin Sippel, Jens Jäger
1Institute of Pharmacy and Food Chemistry, University of Würzburg, Würzburg, Germany.
Abstract:
The macrophage infectivity potentiator (MIP) protein is a major virulence factor of Legionella pneumophila, the causative agent of Legionnaires' disease. MIP belongs to the FK506-binding proteins (FKBP) and is necessary for optimal intracellular survival and lung tissue dissemination of L. pneumophila. We aimed to identify new small-molecule inhibitors of MIP by starting from known FKBP12 ligands. Computational analysis, synthesis, and biological testing of pipecolic acid derivatives revealed a promising scaffold for new MIP inhibitors.
Insights
Researchers identified new potential inhibitors for the macrophage infectivity potentiator (MIP) protein, a key factor in Legionnaires
Area of Science:
- Microbiology and Infectious Diseases
- Drug Discovery and Medicinal Chemistry
Background:
- Legionella pneumophila causes Legionnaires' disease, with the macrophage infectivity potentiator (MIP) protein identified as a major virulence factor.
- MIP is an FK506-binding protein (FKBP) crucial for L. pneumophila's intracellular survival and dissemination within lung tissue.
Purpose of the Study:
- To discover novel small-molecule inhibitors targeting the MIP protein.
- To explore pipecolic acid derivatives as potential scaffolds for MIP inhibition, starting from known FKBP12 ligands.
Main Methods:
- Computational analysis of FKBP12 ligands to guide inhibitor design.
- Chemical synthesis of novel pipecolic acid derivatives.
- Biological testing to evaluate the inhibitory activity of synthesized compounds against MIP.
Main Results:
- Identification of a promising chemical scaffold based on pipecolic acid derivatives.
- Demonstrated potential for these derivatives to inhibit the macrophage infectivity potentiator (MIP) protein.
Conclusions:
- Pipecolic acid derivatives represent a viable starting point for developing new inhibitors of the MIP protein.
- This research opens avenues for novel therapeutic strategies against Legionnaires' disease by targeting MIP.
More Related Videos
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Atypical Pneumonia
Gene Regulation in Microbial Communities: Quorum Sensing

